Manuscripts

  • Tumor response ratio better predicts overall survival in neoadjuvant chemotherapy patients with non-metastatic breast cancer. Miller M, Ottesen RA, Niland JC, Kruper L, Chen SL, Vito C. Ann Surg Oncol. 2014 Oct;21(10):3317-23. PMID: 25059788.
  • Marcinkowski E, Ottesen R, Niland J, Vito C. Acceptance of adjuvant chemotherapy recommendations in early stage hormone positive breast cancer. J Surg Res. 2017 Jun 15;214:79-85. DOI: 10.1016/j.jss.2017.02.035. Epub 2017 Feb 28.PMID: 28624063

Abstracts

  • Obtaining phenotypic data in oncology via natural language processing and data mining of text topics. Ottesen R, Vito C, Niland J. In: International Statistics Institute World Statistics Congress; 2015 Jul 26-31; Rio de Janeiro, Brazil. Invited paper
  • A multivariate economic model for predicting risk-based costs of care for acute leukemia (AL) patients (pts) undergoing allogeneic hematopoietic cell transplant (HCT). Alvarnas JC, Marcucci G, Vanderplas A, Smith E, Murata-Collins J, Levine A, Niland J, Palmer J, Tsai N, Ottesen R, Rabin M, Dzagikian Z, Azimi S, Levine H, Forman SJ. In: The American Society of Hematology; 2016 Dec 3-6; San Diego, CA.
  • Oncological safety of nipple-areola sparing mastectomy in comparison with skin sparing and total mastectomy: Results from a NCI-designated comprehensive cancer center. Bostanci, Z, Wang X, Ottesen, R, Nikowitz, J, Jones, V, Springer, L, Lai, L,Taylor, L , Vito, C, Paz, I, Niland, J,  Kruper, L.  Yim, J. 2017 San Antonio Breast Cancer Symposium, December 5-9, 2017.
  • Mutation Spectrum of Transformed Nodular Lymphocyte Predominant Hodgkin Lymphoma and Comparison with De Novo Diffuse Large B-Cell Lymphoma. Song JY, Egan C, Gong Q, Venkataraman G, Herrera AF, Ottesen R, Niland J, Weisenburger DD, Jaffe E, Chan WC. In: The American Society of Hematology; 2017 Dec 9-12; Atlanta, GA. 
  • Evaluation of Abbyy FineReader Optical Character Recognition Tool Applied to Scanned Outside Medical Records to Facilitate Clinical Research. Hom J, Nikowitz J, Ottesen R, Hughes R, Niland, J. AMIA Joint Summits, Spring 2018.
  • In Search of the Holy Grail: Applying NLP to Identify Recurrent Cancer. Ottesen R, Nikowitz J, Hom J, Kilburn J, Dellinger T, Niland J. Accepted as a Podium Presentation, AMIA Joint Summit, Spring 2019.